1. Home
  2. RNA vs NSIT Comparison

RNA vs NSIT Comparison

Compare RNA & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • NSIT
  • Stock Information
  • Founded
  • RNA 2012
  • NSIT 1988
  • Country
  • RNA United States
  • NSIT United States
  • Employees
  • RNA N/A
  • NSIT N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • NSIT EDP Services
  • Sector
  • RNA Health Care
  • NSIT Technology
  • Exchange
  • RNA Nasdaq
  • NSIT Nasdaq
  • Market Cap
  • RNA 4.0B
  • NSIT 3.7B
  • IPO Year
  • RNA 2020
  • NSIT 1995
  • Fundamental
  • Price
  • RNA $41.81
  • NSIT $120.14
  • Analyst Decision
  • RNA Strong Buy
  • NSIT Buy
  • Analyst Count
  • RNA 16
  • NSIT 3
  • Target Price
  • RNA $69.81
  • NSIT $183.00
  • AVG Volume (30 Days)
  • RNA 3.7M
  • NSIT 307.8K
  • Earning Date
  • RNA 11-06-2025
  • NSIT 10-30-2025
  • Dividend Yield
  • RNA N/A
  • NSIT N/A
  • EPS Growth
  • RNA N/A
  • NSIT N/A
  • EPS
  • RNA N/A
  • NSIT 4.21
  • Revenue
  • RNA $10,729,000.00
  • NSIT $8,355,589,000.00
  • Revenue This Year
  • RNA N/A
  • NSIT $0.34
  • Revenue Next Year
  • RNA $109.60
  • NSIT $4.83
  • P/E Ratio
  • RNA N/A
  • NSIT $28.36
  • Revenue Growth
  • RNA 1.23
  • NSIT N/A
  • 52 Week Low
  • RNA $21.51
  • NSIT $115.68
  • 52 Week High
  • RNA $56.00
  • NSIT $225.38
  • Technical
  • Relative Strength Index (RSI)
  • RNA 45.80
  • NSIT 37.91
  • Support Level
  • RNA $39.83
  • NSIT $118.73
  • Resistance Level
  • RNA $42.42
  • NSIT $129.54
  • Average True Range (ATR)
  • RNA 2.92
  • NSIT 3.62
  • MACD
  • RNA -1.12
  • NSIT -0.69
  • Stochastic Oscillator
  • RNA 38.92
  • NSIT 11.39

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About NSIT Insight Enterprises Inc.

Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.

Share on Social Networks: